| Title: |
Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trial |
| Authors: |
Leon-Ferre, Roberto A.Aff1, Aff7, IDs13058025020701_cor1; Dimitroff, K.Aff2; Yau, C.Aff2; Giridhar, K. V.Aff1; Mukhtar, R.Aff2; Hirst, G.Aff2; Hylton, N.Aff2; Perlmutter, J.Aff3; DeMichele, AAff4; Yee, DAff5; van ’t Veer, LAff2; Rugo, HAff2; Symmans, W. F.Aff6; Goetz, M. P.Aff1; Esserman, L.Aff2; Boughey, J. C.Aff1 |
| Source: |
Breast Cancer Research. 27(1) |
| Database: |
Springer Nature Journals |